Medicenna Therapeutics Corp.
MDNA.TO
TSX
MDNA.TO market cap represents
0.00%
of the sector.
Valuation
MDNA.TO
Low
MDNA.TO
Sector Average
High
Market Cap
58.03M
< 58.03M
> 16.18B
Enterprise Value
37.16M
< 30.00M
> 18.28B
Price/Earnings (TTM)
-3.91
< -10.00
> 10.00
Earnings Per Share Growth (TTM)
65.49%
< -50.00%
> 70.00%
Price/Earnings To Growth (TTM)
--
0.00
12.73
Price/Sales (TTM)
--
-0.633
29,850.000
Price/Book (Q)
6.83
< 0.00
> 20.00
Enterprise Value/Revenue (TTM)
--
-7,765.13
16,478.08
Enterprise Value/EBITDA (TTM)
-2.73
< -10.00
> 0.00
Enterprise Value/EBIT (TTM)
-2.73
< -10.00
> 10.00
Dividends and Shares
MDNA.TO
Low
MDNA.TO
Sector Average
High
Shares Outstanding
78.01M
< 50.00M
> 240.00M
Dividend Per Share (Most Recent)
--
0.00
2.38
Dividend Per Share (TTM)
--
0.00
9.13
Dividend Yield (TTM)
--
0.00%
7.73%
Payout Ratio (TTM)
--
-1,820.24
926.87
Price History
MDNA.TO
Low
MDNA.TO
Sector Average
High
Beta
0.66
< 0.00
4.52
1-Month Total Return
-16.54%
< -20.00%
> 0.00%
3-Month Total Return
-39.43%
< -40.00%
> 0.00%
6-Month Total Return
-48.29%
< -50.00%
> 10.00%
Year to Date Total Return
-33.33%
< -40.00%
> 0.00%
1-Year Total Return
-30.72%
< -40.00%
> 20.00%
2-Year Total Return
39.47%
< 10.00%
> 50.00%
3-Year Total Return
-38.73%
< -40.00%
> 0.00%
5-Year Total Return
-53.91%
< -60.00%
> 240.00%
Profitability
MDNA.TO
Low
MDNA.TO
Sector Average
High
Operating Margin (TTM)
--
-1,170,372.72%
423.48%
Profit Margin (TTM)
--
-1,170,863.63%
1,845.92%
Management Effectiveness
MDNA.TO
Low
MDNA.TO
Sector Average
High
Return on Assets (TTM)
-42.57%
< -60.00%
> -10.00%
Return on Equity (TTM)
--
0.26%
824.40%
Income Statement
MDNA.TO
Low
MDNA.TO
Sector Average
High
Revenue (TTM)
--
-4.27M
370.66B
Total Revenue (TTM)
--
-4.27M
400.28B
Total Revenue Growth (Q YOY)
--
-109.18%
272,400.00%
Revenue Per Share (TTM)
--
-8.53
37,070.00
Gross Profit (TTM)
--
-2.77B
89.40B
EBITDA (TTM)
-13.62M
< -20.00M
> 1.07B
EBIT (TTM)
-13.63M
< -20.00M
> 710.00M
Net Income (TTM)
-19.73M
< -20.00M
> 270.00M
Net Income Avl. to Common (TTM)
-19.73M
< -20.00M
> 270.00M
Earnings Growth (Q YOY)
-1.37%
< -300.00%
> 0.00%
EPS Diluted (TTM)
-0.27
< -5,360.00
> 0.00
EPS Diluted Growth (Q YOY)
9.52%
< -20.00%
> 10.00%
Balance Sheet
MDNA.TO
Low
MDNA.TO
Sector Average
High
Cash and Short-Term Inv. (Q)
20.85M
< 20.00M
> 1.35B
Cash Per Share (Q)
0.27
0.00
> 200.00
Total Current Assets (Q)
22.25M
< 20.00M
> 3.40B
Total Assets (Q)
22.41M
< 20.00M
> 9.63B
Total Current Liabilities (Q)
2.21M
110.30K
> 2.53B
Total Debt (Q)
120.90K
0.00
> 3.10B
Total Liabilities (Q)
10.28M
< 10.00M
> 6.05B
Total Common Equity (Q)
12.13M
< 10.00M
> 3.49B
Total Preferred Equity (Q)
--
0.00
383.90M
Total Equity (Q)
12.13M
< 10.00M
> 3.59B
Current Ratio (Q)
10.086
0.009
> 20.000
Book Value Per Share (Q)
0.16
< 0.00
> 2,130.00
Cash Flow
MDNA.TO
Low
MDNA.TO
Sector Average
High
Cash from Operations (TTM)
-11.95M
< -20.00M
> 710.00M
Cash from Investing (TTM)
-24.20K
< -570.00M
> 0.00
Cash from Financing (TTM)
17.15M
< -180.00M
> 20.00M
Net Change in Cash (TTM)
5.96M
< -30.00M
> 10.00M
Levered Free Cash Flow (TTM)
-8.36M
< -10.00M
> 530.00M
The comparison requires a security to have a minimum 30 day average trading volume of 100,000 at $1 or over, or a $5 minimum price.
* Lowest and highest value for any one individual security in the sector.
